Charlotte B Wagner (Charlotte Wagner)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Multiple Myeloma

Hodgkin Lymphoma

Prognostic Factors

Top Venues

Blood cancer journal

Leukemia & lymphoma

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Charlotte B Wagner, Kelley Julian, Baylee Bryan, Mary N Steinbach, Samuel Shewan, Lindsay Maxwell, Meghan Vigil, Ghulam Rehman Mohyuddin, Amandeep Godara, Brian McClune, Glicelda Galarza Fortuna, Douglas Sborov
Novel chemotherapy combination of carfilzomib with dexamethasone, cyclophosphamide, etoposide and cisplatin (K-DCEP) for the treatment of relapsed/refractory aggressive plasma cell dyscrasias. Leukemia & lymphoma 65 (9) (2024)
Charlotte B Wagner, Kelley Julian, Baylee Bryan, Mary N Steinbach, Samuel Shewan, Lindsay Maxwell, Meghan Vigil, Ghulam Rehman Mohyuddin, Amandeep Godara, Brian McClune, Glicelda Galarza Fortuna, Douglas Sborov
Novel chemotherapy combination of carfilzomib with dexamethasone, cyclophosphamide, etoposide and cisplatin (K-DCEP) for the treatment of relapsed/refractory aggressive plasma cell dyscrasias. Leukemia & lymphoma (2024)
Aimaz Afrough, Hamza Hashmi, Doris K Hansen, Surbhi Sidana, Chul Ahn, Lauren C Peres, Danai Dima, Ciara L Freeman, Omar Castaneda Puglianini, Mehmet H Kocoglu, Shebli Atrash, Peter M Voorhees, Leyla Shune, Joseph P McGuirk, Gary Simmons, Douglas W Sborov, James A Davis, Gurbakhash N M N Kaur, Aishwarya Sannareddy, Christopher J Ferreri, Mahmoud R Gaballa, Scott Goldsmith, Omar Nadeem, Shonali Midha, Charlotte B Wagner, Frederick L Locke, Krina K Patel, Jack Khouri, Larry D Anderson, Yi Lin
Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood cancer journal 14 (1) (2024)
Aimaz Afrough, Hamza Hashmi, Doris K Hansen, Surbhi Sidana, Chul Ahn, Lauren C Peres, Danai Dima, Ciara L Freeman, Omar Castaneda Puglianini, Mehmet H Kocoglu, Shebli Atrash, Peter M Voorhees, Leyla Shune, Joseph P McGuirk, Gary Simmons, Douglas W Sborov, James A Davis, Gurbakhash N M N Kaur, Aishwarya Sannareddy, Christopher J Ferreri, Mahmoud R Gaballa, Scott Goldsmith, Omar Nadeem, Shonali Midha, Charlotte B Wagner, Frederick L Locke, Krina K Patel, Jack Khouri, Larry D Anderson, Yi Lin
Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood cancer journal 14 (1) (2024)
Aimaz Afrough, Hamza Hashmi, Doris K Hansen, Surbhi Sidana, Chul Ahn, Lauren C Peres, Danai Dima, Ciara L Freeman, Omar Castaneda Puglianini, Mehmet H Kocoglu, Shebli Atrash, Peter M Voorhees, Leyla Shune, Joseph P McGuirk, Gary Simmons, Douglas W Sborov, James A Davis, Gurbakhash N M N Kaur, Aishwarya Sannareddy, Christopher J Ferreri, Mahmoud R Gaballa, Scott Goldsmith, Omar Nadeem, Shonali Midha, Charlotte B Wagner, Frederick L Locke, Krina K Patel, Jack Khouri, Larry D Anderson, Yi Lin
Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood cancer journal 14 (1) (2024)
Charlotte B Wagner, Kelley Julian, Baylee Bryan, Mary N Steinbach, Samuel Shewan, Lindsay Maxwell, Meghan Vigil, Ghulam Rehman Mohyuddin, Amandeep Godara, Brian McClune, Glicelda Galarza Fortuna, Douglas Sborov
Novel chemotherapy combination of carfilzomib with dexamethasone, cyclophosphamide, etoposide and cisplatin (K-DCEP) for the treatment of relapsed/refractory aggressive plasma cell dyscrasias. Leukemia & lymphoma 65 (9) (2024)
Jackson T Bowers, Jacob L Anna, Steven M Bair, Kaitlin Annunzio, Narendranath Epperla, Jerrin Joy Pullukkara, Sameh Gaballa, Michael A Spinner, Shuning Li, Marcus R Messmer, Joseph Dan Khoa Nguyen, Emily C Ayers, Charlotte B Wagner, Boyu Hu, Mengyang Di, Scott F Huntington, Fateeha Furqan, Nirav N Shah, Christina Chen, Hatcher J Ballard, Mitchell E Hughes, Elise A Chong, Sunita D Nasta, Stefan K Barta, Daniel J Landsburg, Jakub Svoboda
Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort. Blood advances (2023)
Doris K Hansen, Surbhi Sidana, Lauren C Peres, Christelle M Colin-Leitzinger, Leyla Shune, Alexandria Shrewsbury, Rebecca M Gonzalez, Douglas W Sborov, Charlotte B Wagner, Danai Dima, Hamza Hashmi, Mehmet Hakan Kocoglu, Shebli Atrash, Gary Simmons, Nilesh Kalariya, Christopher Ferreri, Aimaz Afrough, Ankit Kansagra, Peter M Voorhees, Rachid C Baz, Jack Khouri, Melissa Alsina, Joseph P McGuirk, Frederick L Locke, Krina K Patel
Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Christopher J Ferreri, Michelle A T Hildebrandt, Hamza Hashmi, Leyla O Shune, Joseph P McGuirk, Douglas W Sborov, Charlotte B Wagner, M Hakan Kocoglu, Aaron Rapoport, Shebli Atrash, Peter M Voorhees, Jack Khouri, Danai Dima, Aimaz Afrough, Gurbakhash Kaur, Larry D Anderson, Gary Simmons, James A Davis, Nilesh Kalariya, Lauren C Peres, Yi Lin, Murali Janakiram, Omar Nadeem, Melissa Alsina, Frederick L Locke, Surbhi Sidana, Doris K Hansen, Krina K Patel, Omar Castaneda Puglianini
Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy. Blood cancer journal 13 (1) (2023)
Lauren C Peres, Laura B Oswald, Christen M Dillard, Gabriel De Avila, Taiga Nishihori, Brandon J Blue, Ciara Louise Freeman, Frederick L Locke, Melissa Alsina, Omar Castaneda Puglianini, Leyla Shune, Douglas W Sborov, Charlotte B Wagner, Danai Dima, Hamza Hashmi, James A Davis, Mehmet Hakan Kocoglu, Ashraf Z Badros, Shebli Atrash, Gary Simmons, Nilesh Kalariya, Christopher J Ferreri, Larry D Anderson, Aimaz Afrough, Gurbakhash N M N Kaur, Yi Lin, Lawrence Liu, Omar Nadeem, Peter M Voorhees, Jack Khouri, Joseph P McGuirk, Surbhi Sidana, Doris K Hansen, Krina K Patel
Racial and ethnic differences in clinical outcomes among multiple myeloma patients treated with CAR T-cell therapy. Blood advances (2023)
Charlotte B Wagner, Val Adams, Colleen Overley
Alternate dosage formulations of oral targeted anticancer agents. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)